Abstract
The gut microbiota has an extremely important role within the body and it is necessary for the regulation of the metabolism of the host and also for the development of metabolic diseases such as obesity. Here, we show several different factors leading to obesity such as epigenetic changes and how they result in differences to occur in the gut microbiota, along with gut dysbiosis which is caused by disturbances in the microbiota homeostasis. Several studies have been explained in this paper, providing evidence in how these findings can actually decrease the susceptibility of obesity, whether it be by changing an individual’s diet pattern or observing the epigenetic changes which are taking place.
Key points
• The microbiota depends on an individual’s diet, lifestyle, environment, genetics and epigenetic profile.
• Changes of the gut microbiota can increase obesity susceptibility.
• Non-coding RNA has an important role in the metabolic homeostasis in check so if a disturbance occurs it can lead to resistance to obesity.
Similar content being viewed by others
References
Amon P, Sanderson I (2017) What is the microbiome? Arch Dis Child Educ Pract Ed 102(5):257–260
Berg RD (1996) The indigenous gastrointestinal microflora. Trends Microbiol 4(11):430–435
Bernstein BE, Meissner A, Lander ES (2007) The mammalian epigenome. Cell 128(4):669–681
Bien J, Palagani V, Bozko P (2013) The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease? TAG 6(1):53–68
Choi SW, Friso S (2010) Epigenetics: a new bridge between nutrition and health. Adv Nutr 1(1):8–16
Costandi M (2012) Microbes on your mind. Sci Am Mind 23(3):32–37
Crider KS, Yang TP, Berry RJ, Bailey LB (2012) Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role. Adv Nutr 3(1):21–38
Cuevas-Sierra A, Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Martinez JA (2019) Diet, gut microbiota, and obesity: links with host genetics and epigenetics and potential applications. Adv Nutr 10(suppl_1):S17–S30
Dávalos A, Goedeke L, Smibert P, Ramírez CM, Warrier NP, Andreo U, Cirera-Salinas D, Rayner K, Suresh U, Pastor-Pareja JC, Esplugues E (2011) miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. PNAS 108(22):9232–9237
Demehri FR, Frykman PK, Cheng Z, Ruan C, Wester T, Nordenskjöld A, Kawaguchi A, Hui TT, Granström AL, Funari V, Teitelbaum DH (2016) Altered fecal short chain fatty acid composition in children with a history of Hirschsprung-associated enterocolitis. J Pediatr Surg 51(1):81–86
Dempsey J, Zhang A, Cui JY (2018) Coordinate regulation of long non-coding RNAs and protein-coding genes in germ-free mice. BMC genomics 19(1):834
Devaux CA, Raoult D (2018) The microbiological memory, an epigenetic regulator governing the balance between good health and metabolic disorders. Front Microbiol 9:1379
Donaldson GP, Lee SM, Mazmanian SK (2016) Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14(1):20–32
Dupont C, Armant DR, Brenner CA (2009) Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med Sep 27(5):351–357
Hall AB, Tolonen AC, Xavier RJ (2017) Human genetic variation and the gut microbiome in disease. Nat Rev Genet 18(11):690
Janke R, Dodson AE, Rine J (2015) Metabolism and epigenetics. Annu Rev Cell Dev Bi 31:473–496
Kahouli I, Tomaro-Duchesneau C, Prakash S (2013) Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives. J Med Microbiol 62(8):1107–1123
Kalkan R, Altarda M, Tulay P, Tosun O (2019) The interaction between ESRRA and PTH gene methylation and body mass index in post-menopausal cases. Cyprus J Med Sci 4(3):247–250
Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I (2015) Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7(4):2839–2849
Kok DE, Dhonukshe-Rutten RA, Lute C, Heil SG, Uitterlinden AG, van der Velde N, van Meurs JB, van Schoor NM, Hooiveld GJ, de Groot LC, Kampman E (2015) The effects of long-term daily folic acid and vitamin B 12 supplementation on genome-wide DNA methylation in elderly subjects. Clin Epigenetics 7(1):121
Kopelman PG (2000) Obesity as a medical problem. Nature 404(6778):635–643
Kovacheva VP, Mellott TJ, Davison JM, Wagner N, Lopez-Coviella I, Schnitzler AC, Blusztajn JK (2007) Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of Dnmt1 expression. J Biol Chem 282(43):31777–31788
Krautkramer KA, Kreznar JH, Romano KA, Vivas EI, Barrett-Wilt GA, Rabaglia ME, Keller MP, Attie AD, Rey FE, Denu JM (2016) Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues. Mol Cell 64(5):982–992
Kumar H, Lund R, Laiho A, Lundelin K, Ley RE, Isolauri E, Salminen S (2014) Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. MBio 5(6):e02113–e02114
Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Human gut microbes associated with obesity. Nature 444(7122):1022–1023
Li G, Yao W, Jiang H (2014) Short-chain fatty acids enhance adipocyte differentiation in the stromal vascular fraction of porcine adipose tissue. J Nutr 144(12):1887–1895
Liang L, Ai L, Qian J, Fang JY, Xu J (2015) Long noncoding RNA expression profiles in gut tissues constitute molecular signatures that reflect the types of microbes. Sci Rep 5:11763
Liu S, da Cunha AP, Rezende RM, Cialic R, Wei Z, Bry L, Comstock LE, Gandhi R, Weiner HL (2016) The host shapes the gut microbiota via fecal microRNA. Cell Host Microbe 19(1):32–43
Lukovac S, Belzer C, Pellis L, Keijser BJ, de Vos WM, Montijn RC, Roeselers G (2014) Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. MBio 5(4):e01438–e01414
Mahmoud AM, Ali MM (2019) Methyl donor micronutrients that modify DNA methylation and cancer outcome. Nutrients 11(3):608
Marlicz W, Skonieczna-Żydecka K, Dabos KJ, Łoniewski I, Koulaouzidis A (2018) Emerging concepts in non-invasive monitoring of Crohn’s disease. TAG 11:1756284818769076
Mischke M, Plösch T (2013) More than just a gut instinct–the potential interplay between a baby's nutrition, its gut microbiome, and the epigenome. AJPREGU 304(12):R1065–R1069
Morris JR (2001) Genes, genetics, and epigenetics: a correspondence. Science 293(5532):1103–1105
Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, Queipo-Ortuño MI (2013) Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC medicine 11(1):46
Orouji E, Utikal J (2018) Tackling malignant melanoma epigenetically: histone lysine methylation. Clin Epigenetics 10(1):1–16
Paul B, Barnes S, Demark-Wahnefried W, Morrow C, Salvador C, Skibola C, Tollefsbol TO (2015) Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases. Clin epigenetics 7(1):112
Peterson CT, Sharma V, Elmén L, Peterson SN (2015) Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin Exp Immunol 179(3):363–377
Qin Y, Wade PA (2018) Crosstalk between the microbiome and epigenome: messages from bugs. J Biochem 163(2):105–112
Raskov H, Burcharth J, Pommergaard HC (2017) Linking gut microbiota to colorectal cancer. J cancer 8(17):3378
Remely M, Lovrecic L, De La Garza AL, Migliore L, Peterlin B, Milagro FI, Martinez AJ, Haslberger AG (2015) Therapeutic perspectives of epigenetically active nutrients. Brit J Pharmacol 172(11):2756–2768
Romano KA, Rey FE (2018) Is maternal microbial metabolism an early-life determinant of health? Lab animal 47(9):239–243
Rossi M, Amaretti A, Raimondi S (2011) Folate production by probiotic bacteria. Nutrients 3(1):118–134
Sabit H, Cevik E, Tombuloglu H (2019) Colorectal cancer: the epigenetic role of microbiome. World J Clin Cases 7(22):3683–3697
Sarkar S, Abujamra AL, Loew JE, Forman LW, Perrine SP, Faller DV (2011) Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. Anticancer Res 31(9):2723–2732
Shanahan F (2013) The colonic microbiota in health and disease. Curr Opin Gastroen 29(1):49–54
Sharma M, Li Y, Stoll ML, Tollefsbol TO (2019) The epigenetic connection between the gut microbiome in obesity and diabetes. Front Genet 10:1329. https://doi.org/10.3389/fgene.2019.01329
Shekar C, Kaul G (2019) Butyrate: a simple gut microbiota metabolite in the modulation of epigenetic mechanism. Curr Sci 117(3)
Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, Shu J, Chen X, Waterland RA, Issa JPJ (2007) Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet 3(10):2023–2036
Strozzi GP, Mogna L (2008) Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains. J Clin Gastroenterol 42:S179–S184
Tamboli CP, Neut C, Desreumaux P, Colombel JF (2004) Dysbiosis in inflammatory bowel disease. Gut 53(1):1–4
Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474(11):1823–1836
Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, Heim MH, Stoffel M (2011) MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474(7353):649–653
Ursell LK, Metcalf JL, Parfrey LW, Knight R (2012) Defining the human microbiome. Nutr rev 70(suppl_1):S38–S44
Virtue AT, McCright SJ, Wright JM, Jimenez MT, Mowel WK, Kotzin JJ, Joannas L, Basavappa MG, Spencer SP, Clark ML, Eisennagel SH (2019) The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs. Sci Transl Med 11(496):eaav1892
Wang J, Wang P, Li D, Hu X, Chen F (2020) Beneficial effects of ginger on prevention of obesity through modulation of gut microbiota in mice. Eur J Nutr 59(2):699–718
Wu X, Zhang Y (2017) TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet 18(9):517
Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, Honda K (2014) Erratum: obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 506(7488):396
Yuille S, Reichardt N, Panda S, Dunbar H, Mulder IE (2018) Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid. PLoS One 13(7):e0201073
Zeisel S (2017) Choline, other methyl-donors and epigenetics. Nutrients 9(5):445
Zhang S, Yang J, Henning SM, Lee R, Hsu M, Grojean E, Pisegna R, Ly A, Heber D, Li Z (2017) Dietary pomegranate extract and inulin affect gut microbiome differentially in mice fed an obesogenic diet. Anaerobe 48:184–193
Author information
Authors and Affiliations
Contributions
RK: project administration, conceptualization, data handling, writing and reviewing. CC: draft preparation and writing. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
This article does not contain any studies with human participants performed by any of the authors.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Celiker, C., Kalkan, R. Genetic and epigenetic perspective of microbiota. Appl Microbiol Biotechnol 104, 8221–8229 (2020). https://doi.org/10.1007/s00253-020-10849-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-020-10849-9